RECOMBINANT CANCER THERAPEUTIC CYTOKINE
    1.
    发明公开
    RECOMBINANT CANCER THERAPEUTIC CYTOKINE 有权
    重组细胞因子用于癌症治疗

    公开(公告)号:EP3004153A1

    公开(公告)日:2016-04-13

    申请号:EP14807031.1

    申请日:2014-06-04

    IPC分类号: C07K14/52

    摘要: Recombinant therapeutic cytokines (“therakines”) for the treatment of cancer are provided. The recombinant therakines include a truncated region of MDA-7/TL-24 (“M4”) not normally found in nature that has anti-cancer activity and a secretory signal which causes secretion of the therakine from plasmid/virus transduced normal and cancer cells and interaction of the therakine to MDA-7/IL-24 receptors on adjacent, neighboring and distant cancer cells. Therakine interaction results in bystander killing of the target cancer cell as well as adjacent, neighboring and distant cancer cells.